Skip to main content
Year archive

CSL Ltd. — 2020 filings

All 70 regulatory filings released by CSL Ltd. (CSL) in 2020, sourced directly from the official regulator.

70 Filings
2020 Period
2020 filings (70)
Filing Released Lang
Update on UQ-CSL v451 COVID-19 Vaccine 3 pages 126.2KB
Regulatory Filings
2020-12-10 English
New Vaccine Manufacturing Facility 2 pages 153.2KB
Regulatory Filings
2020-11-15 English
Appendix 2A 14 pages 278.5KB
Regulatory Filings
2020-11-10 English
CSLs Annual R&D Investor Briefing 2020 80 pages 9.7MB
Regulatory Filings
2020-10-19 English
Notice of Research & Development Investor Briefing 1
Regulatory Filings
2020-10-18 English
Final Director's Interest Notice 2 pages 185.3KB
Regulatory Filings
2020-10-15 English
Change of Director's Interest Notice 3 pages 209.3KB
Regulatory Filings
2020-10-15 English
Appendix 3G 12 pages 280.4KB
Regulatory Filings
2020-10-15 English
Chairman's Address to Shareholders 20 pages 3.8MB
Regulatory Filings
2020-10-13 English
CSL 2020 AGM Poll Results 3 pages 202.2KB
Regulatory Filings
2020-10-13 English
Appendix 2A 14 pages 278.6KB
Regulatory Filings
2020-10-13 English
CSL Supply Agreement for UQ Vaccine with Commonwealth 2 pages 153.3KB
Regulatory Filings
2020-10-07 English
Appendix 2A 14 pages 234.9KB
Regulatory Filings
2020-10-07 English
Joy Linton named as Chief Financial Officer 2 pages 125.5KB
Regulatory Filings
2020-09-30 English
Appendix 2A 14 pages 235.2KB
Regulatory Filings
2020-09-28 English
Change of Director's Interest Notice 3 pages 203.8KB
Regulatory Filings
2020-09-22 English
Appendix 2A 14 pages 235.2KB
Regulatory Filings
2020-09-22 English
Update - Dividend/Distribution - CSL 5 pages 28.0KB
Regulatory Filings
2020-09-13 English
Change of Director's Interest Notice 3 pages 210.1KB
Regulatory Filings
2020-09-10 English
Appendix 3G 12 pages 273.7KB
Regulatory Filings
2020-09-10 English
Appendix 2A 14 pages 271.8KB
Regulatory Filings
2020-09-10 English
Agreements to Manufacture COVID-19 Vaccines 6 pages 178.6KB
Regulatory Filings
2020-09-06 English
Appendix 3G 12 pages 274.8KB
Regulatory Filings
2020-09-06 English
Appendix 2A 14 pages 272.0KB
Regulatory Filings
2020-09-06 English
Annual Report to shareholders 157 pages 5.8MB
Regulatory Filings
2020-09-03 English
Notice of Annual General Meeting 24 pages 1.2MB
Regulatory Filings
2020-09-03 English
Appendix 4G 10 pages 167.6KB
Regulatory Filings
2020-09-03 English
Shareholder Pack 2020 4 pages 861.9KB
Regulatory Filings
2020-09-03 English
Appendix 2A 14 pages 272.0KB
Regulatory Filings
2020-09-01 English
Change of Director's Interest Notice 3 pages 199.7KB
Regulatory Filings
2020-09-01 English
Change of Director's Interest Notice 3 pages 213.0KB
Regulatory Filings
2020-09-01 English
Appendix 3G 12 pages 278.8KB
Regulatory Filings
2020-08-27 English
Change of Director's Interest Notice 28 pages 431.5KB
Regulatory Filings
2020-08-27 English
Change of Director's Interest Notice 5 pages 307.0KB
Regulatory Filings
2020-08-27 English
Appendix 2A 14 pages 271.8KB
Regulatory Filings
2020-08-26 English
Appendix 2A 14 pages 271.8KB
Regulatory Filings
2020-08-20 English
Statutory Accounts for the Full Year Ended 30 June 2020 118 pages 7.5MB
Regulatory Filings
2020-08-18 English
CSL Results Announcement 7 pages 429.6KB
Regulatory Filings
2020-08-18 English
Dividend/Distribution - CSL 5 pages 27.6KB
Regulatory Filings
2020-08-18 English
CSL Results Presentation 29 pages 3.2MB
Regulatory Filings
2020-08-18 English
Initial Director's Interest Notice 2 pages 130.3KB
Regulatory Filings
2020-08-18 English
ASX Notice of Full Year Results Briefing 2020 1 pag
Regulatory Filings
2020-08-10 English
CSL Appoints New Non Executive Director 1 page 135.
Regulatory Filings
2020-07-15 English
CSL to acquire LateStage Gene Therapy Candidate from uniQure 3 pages 159.5KB
Regulatory Filings
2020-06-24 English
Change in Leadership of CSL's Finance Function 1 pa
Regulatory Filings
2020-06-16 English
CSL to Acquire Biotech Company Vitaeris 2 pages 130.7KB
Regulatory Filings
2020-06-08 English
CEPI CSL UQ Media Release partnering agreement 4 pages 274.0KB
Regulatory Filings
2020-06-04 English
ASA Presentation 20 pages 2.8MB
Regulatory Filings
2020-05-28 English
CSL's Strategic Partnership with Thermo Fisher Scientific 2 pages 125.9KB
Regulatory Filings
2020-05-26 English
New Debt Facilities to Strengthen Maturity Profile 2 pages 195.3KB
Regulatory Filings
2020-05-06 English
Company Update on COVID-19 12 pages 1.5MB
Regulatory Filings
2020-04-08 English
Company Update on COVID-19 1 page 115.9KB
Regulatory Filings
2020-04-07 English
Change of Director's Interest Notice 3 pages 216.2KB
Regulatory Filings
2020-03-23 English
Change of Director's Interest Notice 3 pages 208.2KB
Regulatory Filings
2020-03-16 English
Appendix 2A 14 pages 274.4KB
Regulatory Filings
2020-03-12 English
Update - Dividend/Distribution - CSL 5 pages 28.0KB
Regulatory Filings
2020-03-12 English
Change of Director's Interest Notice 5 pages 305.4KB
Regulatory Filings
2020-03-11 English
Appendix 2A 14 pages 274.4KB
Regulatory Filings
2020-03-05 English
Appendix 3G 12 pages 278.8KB
Regulatory Filings
2020-03-05 English
Appendix 2A 14 pages 274.3KB
Regulatory Filings
2020-03-05 English
Appendix 2A 14 pages 274.2KB
Regulatory Filings
2020-03-05 English
Change of Director's Interest Notice 17 pages 342.0KB
Regulatory Filings
2020-02-20 English
Appendix 3G 12 pages 277.0KB
Regulatory Filings
2020-02-20 English
CSL Statutory Accounts for the Half Year Ended 31/12/2019 30 pages 502.2KB
Regulatory Filings
2020-02-11 English
CSL Half Year Results Announcement 5 pages 274.2KB
Regulatory Filings
2020-02-11 English
CSL Half Year Results Investor Presentation 22 pages 2.7MB
Regulatory Filings
2020-02-11 English
Dividend/Distribution - CSL 5 pages 27.6KB
Regulatory Filings
2020-02-11 English
Notice of Half Year Results Briefing 2020 1 page 23
Regulatory Filings
2020-02-04 English
Appendix 3B 8 pages 213.3KB
Regulatory Filings
2020-01-20 English
2020 JP Morgan Healthcare Conference Presentation 18 pages 2.8MB
Regulatory Filings
2020-01-13 English